nodes	percent_of_prediction	percent_of_DWPC	metapath
Labetalol—Flurbiprofen—UGT2B7—urinary bladder cancer	0.00928	0.32	CrCbGaD
Labetalol—Benazepril—MTHFR—urinary bladder cancer	0.00691	0.238	CrCbGaD
Labetalol—Ketoprofen—CXCL8—urinary bladder cancer	0.00475	0.163	CrCbGaD
Labetalol—Salsalate—PTGS2—urinary bladder cancer	0.00284	0.0978	CrCbGaD
Labetalol—Fenoprofen—PTGS2—urinary bladder cancer	0.00235	0.0808	CrCbGaD
Labetalol—Oedema—Cisplatin—urinary bladder cancer	0.00177	0.00182	CcSEcCtD
Labetalol—Anaphylactoid reaction—Doxorubicin—urinary bladder cancer	0.00177	0.00182	CcSEcCtD
Labetalol—Hypoglycaemia—Doxorubicin—urinary bladder cancer	0.00175	0.00181	CcSEcCtD
Labetalol—Cardiac failure—Doxorubicin—urinary bladder cancer	0.00175	0.00181	CcSEcCtD
Labetalol—Mood swings—Epirubicin—urinary bladder cancer	0.00175	0.0018	CcSEcCtD
Labetalol—Loss of consciousness—Etoposide—urinary bladder cancer	0.00175	0.0018	CcSEcCtD
Labetalol—Lethargy—Doxorubicin—urinary bladder cancer	0.00175	0.0018	CcSEcCtD
Labetalol—Hypotension—Fluorouracil—urinary bladder cancer	0.00174	0.0018	CcSEcCtD
Labetalol—Hypertension—Etoposide—urinary bladder cancer	0.00172	0.00177	CcSEcCtD
Labetalol—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00171	0.00176	CcSEcCtD
Labetalol—Liver function test abnormal—Epirubicin—urinary bladder cancer	0.00171	0.00176	CcSEcCtD
Labetalol—Paraesthesia—Gemcitabine—urinary bladder cancer	0.0017	0.00176	CcSEcCtD
Labetalol—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00169	0.00174	CcSEcCtD
Labetalol—Abdominal pain upper—Epirubicin—urinary bladder cancer	0.00169	0.00174	CcSEcCtD
Labetalol—Orthostatic hypotension—Epirubicin—urinary bladder cancer	0.00169	0.00174	CcSEcCtD
Labetalol—Somnolence—Gemcitabine—urinary bladder cancer	0.00169	0.00174	CcSEcCtD
Labetalol—Affect lability—Doxorubicin—urinary bladder cancer	0.00168	0.00173	CcSEcCtD
Labetalol—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00168	0.00173	CcSEcCtD
Labetalol—Discomfort—Etoposide—urinary bladder cancer	0.00167	0.00172	CcSEcCtD
Labetalol—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00166	0.00171	CcSEcCtD
Labetalol—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00166	0.00171	CcSEcCtD
Labetalol—Somnolence—Fluorouracil—urinary bladder cancer	0.00166	0.00171	CcSEcCtD
Labetalol—Hypotension—Cisplatin—urinary bladder cancer	0.00165	0.0017	CcSEcCtD
Labetalol—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00164	0.00169	CcSEcCtD
Labetalol—Fatigue—Gemcitabine—urinary bladder cancer	0.00164	0.00169	CcSEcCtD
Labetalol—Confusional state—Etoposide—urinary bladder cancer	0.00163	0.00168	CcSEcCtD
Labetalol—Pain—Gemcitabine—urinary bladder cancer	0.00162	0.00167	CcSEcCtD
Labetalol—Constipation—Gemcitabine—urinary bladder cancer	0.00162	0.00167	CcSEcCtD
Labetalol—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00162	0.00167	CcSEcCtD
Labetalol—Mood swings—Doxorubicin—urinary bladder cancer	0.00162	0.00167	CcSEcCtD
Labetalol—Asthenia—Thiotepa—urinary bladder cancer	0.00162	0.00167	CcSEcCtD
Labetalol—Dysuria—Methotrexate—urinary bladder cancer	0.0016	0.00164	CcSEcCtD
Labetalol—Pruritus—Thiotepa—urinary bladder cancer	0.0016	0.00164	CcSEcCtD
Labetalol—Pain—Fluorouracil—urinary bladder cancer	0.0016	0.00164	CcSEcCtD
Labetalol—Paraesthesia—Cisplatin—urinary bladder cancer	0.00159	0.00164	CcSEcCtD
Labetalol—Liver function test abnormal—Doxorubicin—urinary bladder cancer	0.00158	0.00163	CcSEcCtD
Labetalol—Dyspnoea—Cisplatin—urinary bladder cancer	0.00158	0.00162	CcSEcCtD
Labetalol—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.00157	0.00162	CcSEcCtD
Labetalol—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00157	0.00161	CcSEcCtD
Labetalol—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00156	0.00161	CcSEcCtD
Labetalol—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.00156	0.00161	CcSEcCtD
Labetalol—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.00156	0.00161	CcSEcCtD
Labetalol—Angina pectoris—Epirubicin—urinary bladder cancer	0.00156	0.0016	CcSEcCtD
Labetalol—Diarrhoea—Thiotepa—urinary bladder cancer	0.00154	0.00159	CcSEcCtD
Labetalol—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00154	0.00158	CcSEcCtD
Labetalol—Flurbiprofen—PTGS2—urinary bladder cancer	0.00153	0.0527	CrCbGaD
Labetalol—Drowsiness—Methotrexate—urinary bladder cancer	0.00152	0.00157	CcSEcCtD
Labetalol—Depression—Methotrexate—urinary bladder cancer	0.00152	0.00156	CcSEcCtD
Labetalol—Hypotension—Etoposide—urinary bladder cancer	0.00151	0.00156	CcSEcCtD
Labetalol—Pain—Cisplatin—urinary bladder cancer	0.00151	0.00156	CcSEcCtD
Labetalol—Body temperature increased—Gemcitabine—urinary bladder cancer	0.0015	0.00155	CcSEcCtD
Labetalol—Dysuria—Epirubicin—urinary bladder cancer	0.00149	0.00154	CcSEcCtD
Labetalol—Dizziness—Thiotepa—urinary bladder cancer	0.00149	0.00154	CcSEcCtD
Labetalol—Urticaria—Fluorouracil—urinary bladder cancer	0.00148	0.00153	CcSEcCtD
Labetalol—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00148	0.00152	CcSEcCtD
Labetalol—Sweating—Methotrexate—urinary bladder cancer	0.00146	0.0015	CcSEcCtD
Labetalol—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00146	0.0015	CcSEcCtD
Labetalol—Paraesthesia—Etoposide—urinary bladder cancer	0.00146	0.0015	CcSEcCtD
Labetalol—Dyspnoea—Etoposide—urinary bladder cancer	0.00145	0.00149	CcSEcCtD
Labetalol—Somnolence—Etoposide—urinary bladder cancer	0.00144	0.00148	CcSEcCtD
Labetalol—Angina pectoris—Doxorubicin—urinary bladder cancer	0.00144	0.00148	CcSEcCtD
Labetalol—Epistaxis—Methotrexate—urinary bladder cancer	0.00144	0.00148	CcSEcCtD
Labetalol—Vomiting—Thiotepa—urinary bladder cancer	0.00144	0.00148	CcSEcCtD
Labetalol—Drowsiness—Epirubicin—urinary bladder cancer	0.00142	0.00147	CcSEcCtD
Labetalol—Rash—Thiotepa—urinary bladder cancer	0.00142	0.00147	CcSEcCtD
Labetalol—Dermatitis—Thiotepa—urinary bladder cancer	0.00142	0.00146	CcSEcCtD
Labetalol—Agranulocytosis—Methotrexate—urinary bladder cancer	0.00142	0.00146	CcSEcCtD
Labetalol—Headache—Thiotepa—urinary bladder cancer	0.00141	0.00146	CcSEcCtD
Labetalol—Body temperature increased—Cisplatin—urinary bladder cancer	0.0014	0.00144	CcSEcCtD
Labetalol—Fatigue—Etoposide—urinary bladder cancer	0.0014	0.00144	CcSEcCtD
Labetalol—Jaundice—Epirubicin—urinary bladder cancer	0.00139	0.00143	CcSEcCtD
Labetalol—Pain—Etoposide—urinary bladder cancer	0.00139	0.00143	CcSEcCtD
Labetalol—Constipation—Etoposide—urinary bladder cancer	0.00139	0.00143	CcSEcCtD
Labetalol—Ketoprofen—PTGS2—urinary bladder cancer	0.00138	0.0477	CrCbGaD
Labetalol—Dysuria—Doxorubicin—urinary bladder cancer	0.00138	0.00142	CcSEcCtD
Labetalol—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00138	0.00142	CcSEcCtD
Labetalol—Hepatitis—Methotrexate—urinary bladder cancer	0.00137	0.00141	CcSEcCtD
Labetalol—Sweating—Epirubicin—urinary bladder cancer	0.00137	0.00141	CcSEcCtD
Labetalol—Asthenia—Gemcitabine—urinary bladder cancer	0.00136	0.0014	CcSEcCtD
Labetalol—Epistaxis—Epirubicin—urinary bladder cancer	0.00134	0.00138	CcSEcCtD
Labetalol—Pruritus—Gemcitabine—urinary bladder cancer	0.00134	0.00138	CcSEcCtD
Labetalol—Nausea—Thiotepa—urinary bladder cancer	0.00134	0.00138	CcSEcCtD
Labetalol—Feeling abnormal—Etoposide—urinary bladder cancer	0.00134	0.00138	CcSEcCtD
Labetalol—Agranulocytosis—Epirubicin—urinary bladder cancer	0.00133	0.00137	CcSEcCtD
Labetalol—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00133	0.00137	CcSEcCtD
Labetalol—Pruritus—Fluorouracil—urinary bladder cancer	0.00132	0.00136	CcSEcCtD
Labetalol—Drowsiness—Doxorubicin—urinary bladder cancer	0.00132	0.00136	CcSEcCtD
Labetalol—Visual impairment—Methotrexate—urinary bladder cancer	0.00132	0.00136	CcSEcCtD
Labetalol—Hypersensitivity—Cisplatin—urinary bladder cancer	0.0013	0.00134	CcSEcCtD
Labetalol—Bradycardia—Epirubicin—urinary bladder cancer	0.0013	0.00134	CcSEcCtD
Labetalol—Diarrhoea—Gemcitabine—urinary bladder cancer	0.0013	0.00134	CcSEcCtD
Labetalol—Urticaria—Etoposide—urinary bladder cancer	0.00129	0.00133	CcSEcCtD
Labetalol—Jaundice—Doxorubicin—urinary bladder cancer	0.00129	0.00132	CcSEcCtD
Labetalol—Abdominal pain—Etoposide—urinary bladder cancer	0.00128	0.00132	CcSEcCtD
Labetalol—Body temperature increased—Etoposide—urinary bladder cancer	0.00128	0.00132	CcSEcCtD
Labetalol—Hepatitis—Epirubicin—urinary bladder cancer	0.00128	0.00132	CcSEcCtD
Labetalol—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00128	0.00132	CcSEcCtD
Labetalol—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.00127	0.00131	CcSEcCtD
Labetalol—Asthenia—Cisplatin—urinary bladder cancer	0.00127	0.00131	CcSEcCtD
Labetalol—Sweating—Doxorubicin—urinary bladder cancer	0.00126	0.0013	CcSEcCtD
Labetalol—Oedema peripheral—Epirubicin—urinary bladder cancer	0.00126	0.0013	CcSEcCtD
Labetalol—Epistaxis—Doxorubicin—urinary bladder cancer	0.00124	0.00128	CcSEcCtD
Labetalol—Dizziness—Fluorouracil—urinary bladder cancer	0.00123	0.00127	CcSEcCtD
Labetalol—Visual impairment—Epirubicin—urinary bladder cancer	0.00123	0.00127	CcSEcCtD
Labetalol—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.00123	0.00127	CcSEcCtD
Labetalol—Diarrhoea—Cisplatin—urinary bladder cancer	0.00121	0.00125	CcSEcCtD
Labetalol—Alopecia—Methotrexate—urinary bladder cancer	0.00121	0.00124	CcSEcCtD
Labetalol—Vomiting—Gemcitabine—urinary bladder cancer	0.00121	0.00124	CcSEcCtD
Labetalol—Bradycardia—Doxorubicin—urinary bladder cancer	0.0012	0.00124	CcSEcCtD
Labetalol—Mental disorder—Methotrexate—urinary bladder cancer	0.0012	0.00123	CcSEcCtD
Labetalol—Rash—Gemcitabine—urinary bladder cancer	0.0012	0.00123	CcSEcCtD
Labetalol—Dermatitis—Gemcitabine—urinary bladder cancer	0.0012	0.00123	CcSEcCtD
Labetalol—Hypersensitivity—Etoposide—urinary bladder cancer	0.00119	0.00123	CcSEcCtD
Labetalol—Erythema—Methotrexate—urinary bladder cancer	0.00119	0.00123	CcSEcCtD
Labetalol—Headache—Gemcitabine—urinary bladder cancer	0.00119	0.00122	CcSEcCtD
Labetalol—Flushing—Epirubicin—urinary bladder cancer	0.00119	0.00122	CcSEcCtD
Labetalol—Vomiting—Fluorouracil—urinary bladder cancer	0.00119	0.00122	CcSEcCtD
Labetalol—Hepatitis—Doxorubicin—urinary bladder cancer	0.00118	0.00122	CcSEcCtD
Labetalol—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.00118	0.00121	CcSEcCtD
Labetalol—Rash—Fluorouracil—urinary bladder cancer	0.00118	0.00121	CcSEcCtD
Labetalol—Dermatitis—Fluorouracil—urinary bladder cancer	0.00118	0.00121	CcSEcCtD
Labetalol—Headache—Fluorouracil—urinary bladder cancer	0.00117	0.0012	CcSEcCtD
Labetalol—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.00117	0.0012	CcSEcCtD
Labetalol—Asthenia—Etoposide—urinary bladder cancer	0.00116	0.0012	CcSEcCtD
Labetalol—Pruritus—Etoposide—urinary bladder cancer	0.00115	0.00118	CcSEcCtD
Labetalol—Visual impairment—Doxorubicin—urinary bladder cancer	0.00114	0.00117	CcSEcCtD
Labetalol—Alopecia—Epirubicin—urinary bladder cancer	0.00113	0.00116	CcSEcCtD
Labetalol—Nausea—Gemcitabine—urinary bladder cancer	0.00113	0.00116	CcSEcCtD
Labetalol—Vomiting—Cisplatin—urinary bladder cancer	0.00113	0.00116	CcSEcCtD
Labetalol—Vision blurred—Methotrexate—urinary bladder cancer	0.00112	0.00115	CcSEcCtD
Labetalol—Mental disorder—Epirubicin—urinary bladder cancer	0.00112	0.00115	CcSEcCtD
Labetalol—Rash—Cisplatin—urinary bladder cancer	0.00112	0.00115	CcSEcCtD
Labetalol—Dermatitis—Cisplatin—urinary bladder cancer	0.00111	0.00115	CcSEcCtD
Labetalol—Erythema—Epirubicin—urinary bladder cancer	0.00111	0.00115	CcSEcCtD
Labetalol—Diarrhoea—Etoposide—urinary bladder cancer	0.00111	0.00114	CcSEcCtD
Labetalol—Nausea—Fluorouracil—urinary bladder cancer	0.00111	0.00114	CcSEcCtD
Labetalol—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.0011	0.00114	CcSEcCtD
Labetalol—Flushing—Doxorubicin—urinary bladder cancer	0.0011	0.00113	CcSEcCtD
Labetalol—Malaise—Methotrexate—urinary bladder cancer	0.00107	0.00111	CcSEcCtD
Labetalol—Dizziness—Etoposide—urinary bladder cancer	0.00107	0.0011	CcSEcCtD
Labetalol—Muscle spasms—Epirubicin—urinary bladder cancer	0.00107	0.0011	CcSEcCtD
Labetalol—Vertigo—Methotrexate—urinary bladder cancer	0.00107	0.0011	CcSEcCtD
Labetalol—Nausea—Cisplatin—urinary bladder cancer	0.00105	0.00108	CcSEcCtD
Labetalol—Vision blurred—Epirubicin—urinary bladder cancer	0.00105	0.00108	CcSEcCtD
Labetalol—Alopecia—Doxorubicin—urinary bladder cancer	0.00105	0.00108	CcSEcCtD
Labetalol—Mental disorder—Doxorubicin—urinary bladder cancer	0.00104	0.00107	CcSEcCtD
Labetalol—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.00103	0.00106	CcSEcCtD
Labetalol—Vomiting—Etoposide—urinary bladder cancer	0.00103	0.00106	CcSEcCtD
Labetalol—Erythema—Doxorubicin—urinary bladder cancer	0.00103	0.00106	CcSEcCtD
Labetalol—Rash—Etoposide—urinary bladder cancer	0.00102	0.00105	CcSEcCtD
Labetalol—Dermatitis—Etoposide—urinary bladder cancer	0.00102	0.00105	CcSEcCtD
Labetalol—Headache—Etoposide—urinary bladder cancer	0.00102	0.00105	CcSEcCtD
Labetalol—Malaise—Epirubicin—urinary bladder cancer	0.001	0.00103	CcSEcCtD
Labetalol—Discomfort—Methotrexate—urinary bladder cancer	0.001	0.00103	CcSEcCtD
Labetalol—Vertigo—Epirubicin—urinary bladder cancer	0.001	0.00103	CcSEcCtD
Labetalol—Syncope—Epirubicin—urinary bladder cancer	0.000999	0.00103	CcSEcCtD
Labetalol—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000991	0.00102	CcSEcCtD
Labetalol—Palpitations—Epirubicin—urinary bladder cancer	0.000984	0.00101	CcSEcCtD
Labetalol—Confusional state—Methotrexate—urinary bladder cancer	0.000979	0.00101	CcSEcCtD
Labetalol—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000979	0.00101	CcSEcCtD
Labetalol—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000971	0.001	CcSEcCtD
Labetalol—Vision blurred—Doxorubicin—urinary bladder cancer	0.000971	0.001	CcSEcCtD
Labetalol—Nausea—Etoposide—urinary bladder cancer	0.000963	0.000992	CcSEcCtD
Labetalol—Hypertension—Epirubicin—urinary bladder cancer	0.000961	0.00099	CcSEcCtD
Labetalol—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000956	0.000985	CcSEcCtD
Labetalol—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000939	0.000967	CcSEcCtD
Labetalol—Discomfort—Epirubicin—urinary bladder cancer	0.000937	0.000965	CcSEcCtD
Labetalol—Malaise—Doxorubicin—urinary bladder cancer	0.000929	0.000957	CcSEcCtD
Labetalol—Vertigo—Doxorubicin—urinary bladder cancer	0.000926	0.000953	CcSEcCtD
Labetalol—Syncope—Doxorubicin—urinary bladder cancer	0.000924	0.000952	CcSEcCtD
Labetalol—Confusional state—Epirubicin—urinary bladder cancer	0.000916	0.000944	CcSEcCtD
Labetalol—Palpitations—Doxorubicin—urinary bladder cancer	0.000911	0.000938	CcSEcCtD
Labetalol—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000909	0.000936	CcSEcCtD
Labetalol—Oedema—Epirubicin—urinary bladder cancer	0.000909	0.000936	CcSEcCtD
Labetalol—Hypotension—Methotrexate—urinary bladder cancer	0.000907	0.000935	CcSEcCtD
Labetalol—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000906	0.000933	CcSEcCtD
Labetalol—Shock—Epirubicin—urinary bladder cancer	0.000894	0.000921	CcSEcCtD
Labetalol—Hypertension—Doxorubicin—urinary bladder cancer	0.00089	0.000916	CcSEcCtD
Labetalol—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000879	0.000905	CcSEcCtD
Labetalol—Paraesthesia—Methotrexate—urinary bladder cancer	0.000872	0.000898	CcSEcCtD
Labetalol—Discomfort—Doxorubicin—urinary bladder cancer	0.000867	0.000893	CcSEcCtD
Labetalol—Dyspnoea—Methotrexate—urinary bladder cancer	0.000866	0.000892	CcSEcCtD
Labetalol—Somnolence—Methotrexate—urinary bladder cancer	0.000863	0.000889	CcSEcCtD
Labetalol—Dyspepsia—Methotrexate—urinary bladder cancer	0.000855	0.00088	CcSEcCtD
Labetalol—Hypotension—Epirubicin—urinary bladder cancer	0.000849	0.000875	CcSEcCtD
Labetalol—Confusional state—Doxorubicin—urinary bladder cancer	0.000848	0.000873	CcSEcCtD
Labetalol—Oedema—Doxorubicin—urinary bladder cancer	0.000841	0.000866	CcSEcCtD
Labetalol—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000841	0.000866	CcSEcCtD
Labetalol—Fatigue—Methotrexate—urinary bladder cancer	0.000837	0.000862	CcSEcCtD
Labetalol—Pain—Methotrexate—urinary bladder cancer	0.00083	0.000855	CcSEcCtD
Labetalol—Shock—Doxorubicin—urinary bladder cancer	0.000827	0.000852	CcSEcCtD
Labetalol—Paraesthesia—Epirubicin—urinary bladder cancer	0.000816	0.00084	CcSEcCtD
Labetalol—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000813	0.000837	CcSEcCtD
Labetalol—Dyspnoea—Epirubicin—urinary bladder cancer	0.00081	0.000834	CcSEcCtD
Labetalol—Somnolence—Epirubicin—urinary bladder cancer	0.000808	0.000832	CcSEcCtD
Labetalol—Feeling abnormal—Methotrexate—urinary bladder cancer	0.0008	0.000824	CcSEcCtD
Labetalol—Dyspepsia—Epirubicin—urinary bladder cancer	0.0008	0.000824	CcSEcCtD
Labetalol—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000794	0.000818	CcSEcCtD
Labetalol—Hypotension—Doxorubicin—urinary bladder cancer	0.000786	0.000809	CcSEcCtD
Labetalol—Fatigue—Epirubicin—urinary bladder cancer	0.000784	0.000807	CcSEcCtD
Labetalol—Pain—Epirubicin—urinary bladder cancer	0.000777	0.0008	CcSEcCtD
Labetalol—Constipation—Epirubicin—urinary bladder cancer	0.000777	0.0008	CcSEcCtD
Labetalol—Urticaria—Methotrexate—urinary bladder cancer	0.000771	0.000795	CcSEcCtD
Labetalol—Abdominal pain—Methotrexate—urinary bladder cancer	0.000768	0.000791	CcSEcCtD
Labetalol—Body temperature increased—Methotrexate—urinary bladder cancer	0.000768	0.000791	CcSEcCtD
Labetalol—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000755	0.000778	CcSEcCtD
Labetalol—Dyspnoea—Doxorubicin—urinary bladder cancer	0.00075	0.000772	CcSEcCtD
Labetalol—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000749	0.000771	CcSEcCtD
Labetalol—Somnolence—Doxorubicin—urinary bladder cancer	0.000748	0.00077	CcSEcCtD
Labetalol—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000743	0.000765	CcSEcCtD
Labetalol—Dyspepsia—Doxorubicin—urinary bladder cancer	0.00074	0.000762	CcSEcCtD
Labetalol—Fatigue—Doxorubicin—urinary bladder cancer	0.000725	0.000747	CcSEcCtD
Labetalol—Urticaria—Epirubicin—urinary bladder cancer	0.000722	0.000744	CcSEcCtD
Labetalol—Constipation—Doxorubicin—urinary bladder cancer	0.000719	0.000741	CcSEcCtD
Labetalol—Pain—Doxorubicin—urinary bladder cancer	0.000719	0.000741	CcSEcCtD
Labetalol—Abdominal pain—Epirubicin—urinary bladder cancer	0.000718	0.00074	CcSEcCtD
Labetalol—Body temperature increased—Epirubicin—urinary bladder cancer	0.000718	0.00074	CcSEcCtD
Labetalol—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000715	0.000737	CcSEcCtD
Labetalol—Asthenia—Methotrexate—urinary bladder cancer	0.000697	0.000718	CcSEcCtD
Labetalol—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000693	0.000714	CcSEcCtD
Labetalol—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000688	0.000708	CcSEcCtD
Labetalol—Pruritus—Methotrexate—urinary bladder cancer	0.000687	0.000708	CcSEcCtD
Labetalol—Hypersensitivity—Epirubicin—urinary bladder cancer	0.00067	0.00069	CcSEcCtD
Labetalol—Urticaria—Doxorubicin—urinary bladder cancer	0.000668	0.000688	CcSEcCtD
Labetalol—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000665	0.000685	CcSEcCtD
Labetalol—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000665	0.000685	CcSEcCtD
Labetalol—Diarrhoea—Methotrexate—urinary bladder cancer	0.000664	0.000684	CcSEcCtD
Labetalol—Asthenia—Epirubicin—urinary bladder cancer	0.000652	0.000672	CcSEcCtD
Labetalol—Pruritus—Epirubicin—urinary bladder cancer	0.000643	0.000662	CcSEcCtD
Labetalol—Dizziness—Methotrexate—urinary bladder cancer	0.000642	0.000661	CcSEcCtD
Labetalol—Diarrhoea—Epirubicin—urinary bladder cancer	0.000622	0.00064	CcSEcCtD
Labetalol—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.00062	0.000638	CcSEcCtD
Labetalol—Vomiting—Methotrexate—urinary bladder cancer	0.000617	0.000636	CcSEcCtD
Labetalol—Rash—Methotrexate—urinary bladder cancer	0.000612	0.000631	CcSEcCtD
Labetalol—Dermatitis—Methotrexate—urinary bladder cancer	0.000612	0.00063	CcSEcCtD
Labetalol—Headache—Methotrexate—urinary bladder cancer	0.000608	0.000627	CcSEcCtD
Labetalol—Asthenia—Doxorubicin—urinary bladder cancer	0.000603	0.000621	CcSEcCtD
Labetalol—Dizziness—Epirubicin—urinary bladder cancer	0.000601	0.000619	CcSEcCtD
Labetalol—Pruritus—Doxorubicin—urinary bladder cancer	0.000595	0.000613	CcSEcCtD
Labetalol—Vomiting—Epirubicin—urinary bladder cancer	0.000578	0.000595	CcSEcCtD
Labetalol—Nausea—Methotrexate—urinary bladder cancer	0.000577	0.000594	CcSEcCtD
Labetalol—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000575	0.000593	CcSEcCtD
Labetalol—Rash—Epirubicin—urinary bladder cancer	0.000573	0.00059	CcSEcCtD
Labetalol—Dermatitis—Epirubicin—urinary bladder cancer	0.000572	0.00059	CcSEcCtD
Labetalol—Headache—Epirubicin—urinary bladder cancer	0.000569	0.000586	CcSEcCtD
Labetalol—Dizziness—Doxorubicin—urinary bladder cancer	0.000556	0.000573	CcSEcCtD
Labetalol—Nausea—Epirubicin—urinary bladder cancer	0.00054	0.000556	CcSEcCtD
Labetalol—Vomiting—Doxorubicin—urinary bladder cancer	0.000535	0.000551	CcSEcCtD
Labetalol—Rash—Doxorubicin—urinary bladder cancer	0.00053	0.000546	CcSEcCtD
Labetalol—Dermatitis—Doxorubicin—urinary bladder cancer	0.00053	0.000546	CcSEcCtD
Labetalol—Headache—Doxorubicin—urinary bladder cancer	0.000527	0.000543	CcSEcCtD
Labetalol—Nausea—Doxorubicin—urinary bladder cancer	0.000499	0.000514	CcSEcCtD
